Filing Flows › Milestone Pharmaceuticals (MIST) › Q2 2026 › vs Q1 2026
Milestone Pharmaceuticals (MIST) Q2 2026 vs Q1 2026 (quarter over quarter)
Milestone Pharmaceuticals's revenue rose $321K (+135%) from $238K in Q1 2026 to $559K in Q2 2026.
Milestone Pharmaceuticals, Q2 2026: revenue $559K, net loss $28.6M, operating cash flow −$22.7M. The chart draws each line against Q1 2026, the increases inside each band.
Every line
| Line | Q2 2026 | Q1 2026 | Change | % |
|---|---|---|---|---|
| Revenue | $559K | $238K | $321K | +135% |
| Net loss | $28.6M | $26.1M | $2.5M | +10% |
| Costs & expenses | $29.2M | $26.3M | $2.9M | +11% |
| Operating costs | $26.2M | $23.9M | $2.3M | +10% |
| Interest & other, net | $3.0M | $2.4M | $581K | +24% |
| Cost of revenue | $32K | $14K | $18K | +129% |
| Research & development | $3.5M | $3.3M | $258K | +8% |
| Operating cash sources | $28.6M | $26.1M | $2.5M | +10% |
| Depreciation & amortization | $57K | $56K | $1K | +2% |
| Share-based compensation | $1.3M | $1.3M | $56K | +4% |
| Working capital & other | $4.5M | $8.7M | −$4.2M | -48% |
| Cash used in operations | $22.7M | $16.1M | $6.7M | +41% |
| Net loss absorbed | $28.6M | $26.1M | $2.5M | +10% |
Questions
How much did Milestone Pharmaceuticals's revenue grow quarter over quarter in Q2 2026?
Milestone Pharmaceuticals's revenue rose $321K (+135%) from $238K in Q1 2026 to $559K in Q2 2026.